About

Zdravka Misic, Innovation Project Manager at dsm-firmenich, holds a PhD in Pharmaceutical Sciences from the University of Basel (Switzerland). She started her career as a formulation
scientist at Teva in 2004. In 2009, she moved to Switzerland to ETH Zürich as an ESKAS (Swiss Government Excellence Scholarships for Foreign Scholars) scholarship holder. Dr Misic
joined dsm-firmenich in 2014 and, since then, has worked as a Principal Pharmaceutical Scientist on developing new delivery systems for dsm-firmenich’s products and collaborated closely
with marketing in presenting them to customers.

She also leads external collaborations with academic partners (including the International University of Applied Sciences and ETH Zürich)
and established CDMOs within the pharmaceutical industry. Since January 2024, Dr Misic has switched to the position of an Innovation Project Manager, dedicated to pharma innovation
projects in the specific development of new oral solid CBD formulations with enhanced bioavailability.

Contributions

EXPERT VIEW

CANNABIDIOL DELIVERY THAT IS ON THE “TIP OF THE TONGUE”

Zdravka Misic explores how formulation expertise can be applied to overcome the low bioavailability of cannabinoids and how innovation in orally disintegrating tablets is driving progress for cannabidiol-based therapeutics.